25 . 26 JANH O T E L S O L V E R D E

2019

Organização

Apoio

Agência Oficial

8 Inscrições disponíveis em: www.lab52.pt/3bcw

Médicos Especialistas: 70,00€

Médicos Internos: 60,00€

Estudantes: 40,00€

Patrocínio Científico

26th January 2019

Adjustment of APPHINITY evidence in the real world practice TBC

Progression after iCDK: what could be the best sequence M. De Laurentiis

Is there a new combo in the treatment of ABC? Immunotherapy + CT in triple negativeGiuseppe Curigliano

Discussion

10:45h

11:05h

11:25h

11:35hHighlights in Breast Cancer treatmentChairs: Luís Costa; Susana Sousa; TBC

Capability to find different prognostic subgroups to define adjuvant treatmentBerta Sousa

Genomic Driven Oncology- who really benefits? TBC

Discussion

10:45hDisease characterization by genomic profilesChairs: Fernando Schmitt; Manuel Teixeira; TBC

11:35h

11:55h

12:15h

12:35h

De-escalation BC surgery after neoadjuvant treatment Isabel Rubio

Breast reoperation after lumpectomy: how to avoid it? André Magalhães

Factors influencing surgeons attitude toward axillary dissection in adjuvant settingViviana Galimberti

Discussion

08:30h

09:00h

09:30h

10:00h

08:30hSurgical issues in Breast CancerChairs: TBC

10:15h Coffee break

25th January 2019

Financial autonomy F. Rocha Gonçalves

The role of clinical nurses: the bridge between doctors and patients TBC

Integrative medicine TBC

Follow-up strategies: dealing with the increasing treatment complexity of patients

J.L. Passos Coelho

Discussion

09:00h

09:00h

09:20h

09:40h

10:00h

10:30h

Screening implications according to tumour phenotype Cláudia Vieira

Rethinking whole brain radiotherapy TBC

Is there any benefit for intrathecal chemotherapy? Cláudia Caeiro

Practical dilemmas in deciding systemic treatment Antonio Llombart

Imaging follow-up of patients: when and how? Mavilde Arantes

Discussion

15:30h

15:30h

15:50h

16:10h

16:25h

16:55h

17:15h

Brain and leptomeningeal metastasisChairs: Paulo Cortes; Deolinda Pereira; TBC

Clinical value of mutations beyond BRCA Ana Luísa Peixoto

What is new in systemic treatment approach in BRCA patients?

- Neo/adjuvant Judith Balmaña

- Palliative Cristina Oliveira

Fertility potential and fertility-sparing strategies in BRCA patients TBC

Discussion

11:15h

11:15h

11:35h

11:55h

12:15h

12:35h

Hereditary Breast CancerChairs: Fátima Vaz; Sandra Bento; Rosário Couto

10:45h Coffee break

Breast Cancer Units: Challenges for the futureChairs: TBC

14:15hDebate: Psychosocial needs and care- questions and answers

Patient, Social Assistant, Clinician and Lawyer perspectives Cristina Nogueira; Monick Leal; Gabriela Sousa

12:50h Lunch

15:15h Coffee break

08:30h Opening Session